SCHEMBL6070176

SCHEMBL6070176

CN1CCN(S(=O)(=O)c2ccc(Nc3nccc(-c4ccnn4-c4ccccc4)n3)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 15/20 0.54
CHUK O15111 12/20 0.54
CCNE1 P24864 1/20 0.51
CDK2 P24941 1/20 0.51
PDE5A O76074 4/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070386 0.89 IKBKB (0.44) IKBKBCHUKCCNE1CDK2PDE5A
SCHEMBL6070820 0.89 SYK (0.44) IKBKBCHUKCCNE1CDK2PDE5A
SCHEMBL6069652 0.82 CDK2 (0.62) IKBKBCHUKCDK2
SCHEMBL3519995 0.77 IKBKB (0.63) IKBKBCHUKPDE5A
SCHEMBL3516540 0.77 IKBKB (0.66) IKBKBCHUK
SCHEMBL6070155 0.76 CAMK2D (0.61) IKBKBCHUKCDK2
SCHEMBL3522759 0.76 IKBKB (0.61) IKBKBCHUKPDE5A
SCHEMBL6070706 0.75 CDK1 (0.51) CDK2
SCHEMBL6070419 0.75 AURKA (0.52) IKBKBCHUKCDK2
SCHEMBL6069779 0.75 JAK2 (0.57) CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109204-B2 controlling signal transduction; anticancer agents, antitumor agents, atherosclerosis, vision defects, antidiabetic agents, antiinflammatory agents MERCK & CO., INC. (US) 2006-09-19 US disclosed